Assistant Professor, Internal Medicine, Mayo Medical School
Hematology
Dr. Luis F. Porrata, MD
|
|
Give Review
Dr. Luis F. Porrata works in the field of Hematology. He went to medical school at State University of New York Upstate Medical University. Luis Porrata is a published doctor as well. He has 101 publications published. The latest was: 63-year-old woman with fever and right flank pain. He accepts all Medicare patients.
Publications
- Large B-cell transformation in nodular lymphocyte predominant Hodgkin Lymphoma: forty-year experience from a single institution.
- Personalized risk prediction for event-free survival at 24 months in patients with diffuse large b-cell Lymphoma.
- Hodgkin transformation of chronic lymphocytic Leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.
- Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin Lymphoma.
- Infused AutoGraft Lymphocyte to Monocyte Ratio and Survival in Diffuse Large B-Cell Lymphoma.
- Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outc...
- Incidence of Supraventricular Arrhythmias during Autologous Peripheral Blood Stem Cell Transplantation.
- Absolute monocyte count at diagnosis and survival in mantle cell Lymphoma.
- Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning.
- A phase i trial of immunostimulatory CpG 7909 oligodeoxynucleotide and (90) yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-hodgkin Lymphoma.
- Patients with immunoglobulin light chain amyloidosis undergoing autologous stem Cell transplantation have superior outcomes compared with patients with multiple myelom...
- Treatment with low doses of polyclonal immunoglobulin improves B cell function during Immune reconstitution in a murine model.
- Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem Cell mobilization.
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin''s Lymphoma.
- Peripheral blood lymphocyte and monocyte recovery and survival in Acute leukemia post myeloablative allogeneic hematopoietic stem cell transplant.
- Relapsed hepatosplenic T-cell Lymphoma heralded by a solitary skin nodule.
- Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory Lymphomas.
- Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell Lymphoma.
- Predicting survival for diffuse large B-cell Lymphoma patients using baseline neutrophil/lymphocyte ratio.
- Diagnosis and management of Waldenström Macroglobulinemia: Mayo stratification of Macroglobulinemia and risk-adapted therapy (mSMART) guidelines.
- A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin Lymphoma.
- New-onset lymphopenia assessed during routine follow-up is a risk factor for relapse postautologous peripheral blood hematopoietic stem Cell transplantation in patient...
- Host immunity affects survival in myelodysplastic Syndromes: Independent prognostic value of the absolute lymphocyte count.
- Use of various offset settings in the Fenwal Amicus during hematopoietic progenitor Cell collection to increase lymphocyte yield and reduce cross-Cellular contamination.
- Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell Lymphoma.
- Autologous stem Cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisc...
- mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative Disorders (EBV-LPD).
- Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin Lymphoma: a prospective study.
- Malignant primary cardiac tumors: review of a single institution experience.
- Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's Lymphoma.
- AMD3100 affects autoGraft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphoma.
- Androgenic therapy for Waldenstrom's Macroglobulinemia.
- Absolute values of immunoglobulin free light chains are prognostic in patients with primary Systemic amyloidosis undergoing peripheral blood stem cell transplantation.
- Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary Systemic amyloidosis.
- Primary mammary (non-Hodgkin) lymphoma presenting as locally advanced breast Cancer.
- Prognostication of survival using cardiac troponins and N-terminal pro-Brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral bl...
- Superior survival in primary Systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.
- Therapeutic options in patients with Lymphoma and severe liver dysfunction.
- Imatinib therapy for hypereosinophilic Syndrome and other eosinophilic disorders.
- Infused autoGraft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma.
- Impact of clinical factors and alloGraft leukocyte content on post-transplant lymphopenia, monocytopenia, and survival in patients undergoing allogeneic peripheral blo...
- Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transp...
- Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin Lymphoma.
- The dynamic human immune response to Cancer: it might just be rocket science.
- Autograft mediated adoptive immunotherapy of Cancer in the context of autologous stem cell transplantation.
- Failure of Autologous Hematopoietic Stem Cell Transplantation to Prevent Relapse of Neuromyelitis Optica.
- Autologous stem Cell transplant for immunoglobulin light chain amyloidosis: a status report.
- Treatment with polyclonal immunoglobulin during T-Cell reconstitution promotes naive T-Cell proliferation.
- A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem Cell conditioning regimen in patients with multiple myeloma.
- Interleukin-15 affects patient survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-Hodgkin Lymphomas.
- Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple Myeloma: a retrospective study.
- Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with Chronic lymphocytic leukaemia.
- Germinal center B (GCB) and non-GCB cell-like diffuse large B cell Lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
- Host immunity and survival.
- Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic Leukemia: analysis after a minimum follow-up of 5 years.
- Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem Cell transplantation ...
- Myelodysplastic Syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
- The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin Lymphoma.
- Absolute lymphocyte count predicts overall survival in follicular Lymphomas.
- Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular Lymphomas.
- Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell Lymphoma not responding to...
- Peripheral blood stem cell transplant for POEMS Syndrome is associated with high rates of engraftment Syndrome.
- Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin Lymphoma.
- The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin''s Lymphoma.
- Re-infused autologous Graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation.
- Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin''s Disease.
- Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast Cancer.
- Immunomodulation of early enGrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
- The pharmacologic basis of high dose chemotherapy with haematopoietic stem Cell support for solid tumours.
- Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin Lymphoma.
- Immune reconstitution after autologous hematopoietic stem cell transplantation.
- Thrombocytopenia after iron dextran administration in a patient with severe iron deficiency Anemia.
- 76-year-old man with retroperitoneal bleeding after proStatectomy.
- Idiopathic thrombocytopenic purpura associated with breast Cancer: a case report and review of the current literature.
- 63-year-old woman with fever and right flank pain.
- Infused peripheral blood autoGraft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopo...
- Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for Acute myelogenous leukemia.
- Timely reconstitution of Immune competence affects clinical outcome following autologous stem cell transplantation.
- A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem Cell conditioning regimen in patients with multiple myeloma.
- Risk-adjusted manipulation of melphalan dose before stem Cell transplantation in patients with amyloidosis is associated with a lower response rate.
- The dose of infused lymphocytes in the autoGraft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in...
- Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin''s Lymphoma.
- Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic Leukemia.
- Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem Cell transplantation in...
- Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell Lymphoma.
- Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem Cell transplan...
- Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular Lymphomas.
- Autologous HSC transplant in t-MDS/AML using Cells harvested prior to the development of the secondary malignancy.
- Dysgranulopoiesis is an independent adverse prognostic factor in Chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q.
- Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT.
- Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or pr...
- CD34+ Cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melph...
- Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell Lymphoma.
- The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of Acute leukemia.
- Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization.
- Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.
- A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive Lymphoma.
- Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in Acute myelogenous leukemia.
- Failure of front-line autologous transplant in anaplastic Lymphoma kinase-positive diffuse large B-cell Lymphoma.
- Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell Lymphomas: phase I study.
Schools
SUNY Upstate Medical University Syracuse
Mayo Clinic Rochester
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
Education
-
Mayo School of Graduate Medical Education -
State University of New York Upstate Medical University
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1992784391 | |
| NPPES Provider LastName | PORRATA | |
| NPPES Provider FirstName | LUIS | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 335.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 3.58 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1992784391 |
| Last Name Of The Provider | PORRATA |
| First Name Of The Provider | LUIS |
| View All |
Similar Doctors
|
|
Dr. Thomas E. Witzig, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Suzanne R. Hayman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mateusz Opyrchal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. S Vincent Rajkumar, MD |
|
|
Dr. Vilmarie Rodriguez, MD |
|
|
Dr. Michael E. Menefee, MD |
|
|
Dr. Akash Patnaik, MD |
|
|
Dr. Carrie A. Thompson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia J. Wetmore, MD |
|
|
Dr. Matthew P. Goetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Miller, MD |
|
|
Dr. Andreas S. Beutler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Andrew C. Hendrickson
This Doctor is OpenDoctor Recommended.
|